A Multicenter, Randomized Controlled Phase II Study of Short-Course Radiotherapy Followed by Sequential PD-1 Inhibitor and FOLFOX Chemotherapy Versus Long-Course Chemoradiotherapy for High-Risk Locally Advanced pMMR/MSS Lower Rectal Adenocarcinoma (STAR Trial)
Conditions
Rectal Adenocarcinoma · High-risk Locally Advanced · Short-course Radiotherapy (SCRT) · Immunotherapy · FOLFOX
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China